J3111 – Injection, romosozumab-aqqg, 1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ3111
- Long description
- Injection, romosozumab-aqqg, 1 mg
- Short description
- Inj. romosozumab-aqqg 1 mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- October 1, 2019
- Last change
- October 1, 2019 – No change
Frequently asked questions
What is HCPCS code J3111?
J3111 is a HCPCS Level II code for injection, romosozumab-aqqg, 1 mg.
Does Medicare cover J3111?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J3055 – Injection, talquetamab-tgvs, 0.25 mg
- J3060 – Injection, taliglucerase alfa, 10 units
- J3070 – Injection, pentazocine, 30 mg
- J3090 – Injection, tedizolid phosphate, 1 mg
- J3095 – Injection, telavancin, 10 mg
- J3101 – Injection, tenecteplase, 1 mg
- J3105 – Injection, terbutaline sulfate, up to 1 mg
- J3110 – Injection, teriparatide, 10 mcg
- J3120 – Injection, testosterone enanthate, up to 100 mg
- J3121 – Injection, testosterone enanthate, 1 mg
- J3130 – Injection, testosterone enanthate, up to 200 mg
- J3140 – Injection, testosterone suspension, up to 50 mg
- J3145 – Injection, testosterone undecanoate, 1 mg
- J3150 – Injection, testosterone propionate, up to 100 mg
- J3230 – Injection, chlorpromazine hcl, up to 50 mg
- J3240 – Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.